Part of 1. Questions to the First Minister – in the Senedd at 1:43 pm on 17 March 2020.
Well, I thank Rhun ap Iorwerth for that, and thank you to him and to Adam Price for their participation in discussions on this yesterday. As far as testing policy is concerned, the advice that I have to follow is the advice provided to me by the Chief Medical Officer for Wales and those representatives from Wales who sit on the scientific advisory group. There are many different views, I understand that. There are many serious scientists who have nuanced views on testing policy. I cannot pick and choose between different views that are there in the mix on this matter. I have to rely on those people who are employed to provide the Welsh Government with the most expert advice they are able to provide, and who have a fine-grained understanding of the circumstances here in Wales. Their advice yesterday, it was the advice of other chief medical officers as well, is that this is not the point in the progress of the disease where using considerable resources for mass testing is the most effective way of putting safeguards in place. Other people may disagree, I understand that, but what I am saying is that I don't have a choice but to follow the advice of those people who we employ to advise us. If I move away from that, then the rock on which the advice that I provide to people in Wales and to the health service has been kicked away from under us, and I will not do that. Their advice is under development—the Strategic Advisory Group of Experts on Immunization was talking about this matter again today—and if that advice changes in view of further evidence and further debate inside the expert community then, of course, we will follow that changing advice. But, as of yesterday, the advice was clear and I will follow that advice in Wales.
As far as key workers as concerned, I know that the Member will be aware that we are making an announcement today about testing key clinical workers in order to facilitate their return as rapidly as possible to the workplace. We will identify those groups of clinical workers who we are able to do that with immediately, and then there will be an increase in capacity so that we can bring more key workers within that testing regime.